Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2026-01-25 @ 7:59 AM
Study NCT ID:
NCT05469750
Status:
UNKNOWN
Last Update Posted:
2022-07-22
First Post:
2022-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dalpiciclib Plus Letrozole and Capecitabine
Sponsor:
Fujian Medical University Union Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2022YF035-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None